2009 financial summary

2009 financial summary (audited)

Revenue (in thousands)

Foundations and corporations

$160,213

US Government

56,800

Other governments, nongovernmental organizations (NGOs), multilaterals

20,271

Individuals/other

14,713

Investments

4,595

Total revenue

$256,592

 

 

Expenses (in thousands)

Program services

Programs:

 

Emerging and epidemic diseases

$25,116

Health technologies

13,297

Maternal and child health and nutrition

10,195

Reproductive health

19,696

Vaccines and immunization

32,234

Subtotal programs

100,538

Program subawards

$125,472

Subtotal program services

$226,010

 

 

Support services

Management and general

24,078

Bid and proposal

2,109

Fundraising

1,258

Subtotal support services

27,445

Total expenses

$253,455

Assets and liabilities

Assets (in thousands)

Grants receivable

$459,288

Invested grant funds

292,808

Cash and cash equivalents

72,521

Other

25,217

Total assets

$849,834

 

 

Net assets and liabilities (in thousands)

Net assets

Grant funds temporarily restricted

$787,828

Unrestricted assets

17,476

Permanently restricted assets

3,365

Total net assets

808,669

Current liabilities

41,165

Total net assets and liabilities

$849,834

Figures are presented in US dollars.

Notes: The above financial summary is an excerpt from PATH’s audited financial statements, which are audited by the firm Clark Nuber P.S. Full copies are available on our website at www.path.org.

PATH is an international, nonprofit, nongovernmental organization. Our mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviors. Contributions to PATH are tax-exempt under US IRS code 501(c)(3).

Innovation funding icon. Visit the Individual donors page to learn how support from individuals and family foundations fuels PATH’s innovations.

Sources of revenue

Sources of revenue: 62.5% foundations and corporations; 22.1% US government; 7.9% other governments, NGOs, multilaterals; 5.7% individuals/other; 1.8% investments.

Expense allocation

Expense allocation: 89.2% program services; 9.5% management and general; 0.8% bid and proposal; 0.5% fundraising.

Use of fundsUse of funds: 32.1% vaccines and immunization; 25.0% emerging and epidemic diseases; 19.6% reproductive health; 13.2% health technologies; 10.1% maternal and child health and nutrition.